Ayer Capital Management as of Dec. 31, 2012
Portfolio Holdings for Ayer Capital Management
Ayer Capital Management holds 26 positions in its portfolio as reported in the December 2012 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Grifols S A Sponsored Adr R (GRFS) | 11.1 | $21M | 815k | 25.93 | |
| Teva Pharmaceutical Industries (TEVA) | 9.3 | $18M | 476k | 37.34 | |
| ArthroCare Corporation | 8.2 | $16M | 453k | 34.59 | |
| Endologix | 7.5 | $14M | 1.0M | 14.24 | |
| Celgene Corp right 12/31/2011 | 7.5 | $14M | 2.2M | 6.41 | |
| Boston Scientific Corporation (BSX) | 6.1 | $12M | 2.0M | 5.73 | |
| Ariad Pharmaceuticals | 5.7 | $11M | 568k | 19.18 | |
| Insmed (INSM) | 5.2 | $9.9M | 1.5M | 6.69 | |
| McKesson Corporation (MCK) | 5.1 | $9.8M | 101k | 96.96 | |
| Hologic (HOLX) | 4.9 | $9.4M | 467k | 20.01 | |
| Express Scripts Holding | 4.1 | $7.9M | 146k | 54.00 | |
| Peregrine Pharmaceuticals | 3.8 | $7.2M | 5.4M | 1.32 | |
| Cardinal Health (CAH) | 3.5 | $6.6M | 161k | 41.18 | |
| Novavax | 2.8 | $5.2M | 2.8M | 1.89 | |
| Universal Health Services (UHS) | 2.7 | $5.2M | 107k | 48.35 | |
| ShangPharma | 2.4 | $4.5M | 523k | 8.59 | |
| Chemocentryx | 2.3 | $4.3M | 396k | 10.94 | |
| Threshold Pharmaceuticals | 1.8 | $3.3M | 793k | 4.21 | |
| Biolinerx Ltd-spons | 1.5 | $2.9M | 1.2M | 2.53 | |
| Peregrine Pharmaceuticals Inc. cmn | 1.4 | $2.6M | 2.0M | 1.32 | |
| Health Management Associates | 0.9 | $1.8M | 192k | 9.32 | |
| Cyclacel Pharmaceuticals | 0.6 | $1.1M | 221k | 4.85 | |
| Biomira Inc Cmn Stock cmn | 0.5 | $1.0M | 535k | 1.92 | |
| AtriCure (ATRC) | 0.5 | $893k | 129k | 6.90 | |
| Omeros Corporation (OMER) | 0.5 | $881k | 170k | 5.19 | |
| Palatin Technologies | 0.3 | $672k | 1.1M | 0.60 |
